ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,401Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 359

$792K Total Retail Price of All Prescriptions

Rank: 11 out of 359

690 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

8% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 13,510 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 714 657 1 7
WARFARIN SODIUM 487 482 2 10
SIMVASTATIN 486 423 3 1
AMLODIPINE BESYLATE 465 464 4 4
OMEPRAZOLE 436 395 5 6
LISINOPRIL 336 284 6 3
GABAPENTIN 282 277 7 16
HYDROCHLOROTHIAZIDE 274 255 8 15
FUROSEMIDE 269 260 9 5
POLYETHYLENE GLYCOL 3350 246 246 10 95
POTASSIUM CHLORIDE 241 239 11 20
HYDROCODONE-ACETAMINOPHEN 240 212 S3 12 2
DONEPEZIL HCL 232 232 13 23
METOPROLOL TARTRATE 229 218 14 9
METOPROLOL SUCCINATE 225 217 15 8
MIRTAZAPINE 220 220 16 64
BUMETANIDE 219 219 17 133
ALENDRONATE SODIUM 198 186 18 32
ZOLPIDEM TARTRATE 166 149 19 36
ATENOLOL 165 165 20 18
NAMENDA 163 163 21 30
TRAMADOL HCL 161 148 22 24
PANTOPRAZOLE SODIUM 160 159 23 28
LOSARTAN POTASSIUM 154 150 24 22
PREDNISONE 150 149 25 33
CYMBALTA 148 131 26 47
METFORMIN HCL 142 119 27 12
ATORVASTATIN CALCIUM 137 136 28 11
ESCITALOPRAM OXALATE 127 119 29 70
DIGOXIN 125 125 30 21
IPRATROPIUM-ALBUTEROL 113 113 31 179
CITALOPRAM HBR 109 107 32 37
LIDODERM 109 109 32 111
SERTRALINE HCL 103 87 34 27
CARVEDILOL 103 103 34 14
ALLOPURINOL 96 84 36 52
AZITHROMYCIN 90 84 37 79
CARBIDOPA-LEVODOPA 88 88 38 44
GLIMEPIRIDE 86 82 39 76
FLUTICASONE PROPIONATE 84 62 40 35
RANITIDINE HCL 84 67 40 53
ENALAPRIL MALEATE 83 74 42 42
CEPHALEXIN 83 82 42 101
PRAVASTATIN SODIUM 75 72 44 25
VENLAFAXINE HCL ER 73 69 45 97
EXELON 71 71 46 119
SPIRONOLACTONE 71 71 46 62
CLOPIDOGREL 70 67 48 19
TAMSULOSIN HCL 69 69 49 17
FAMOTIDINE 68 68 50 66
PRAMIPEXOLE DIHYDROCHLORIDE 65 65 51 124
FENTANYL 65 65 S2 51 58
PLAVIX 65 63 51 31
AMIODARONE HCL 63 63 54 118
LANTUS 62 62 55 67
LEVOFLOXACIN 61 60 56 174
TRIAMTERENE-HCTZ 61 60 56 164
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 58 269
OLANZAPINE 58 49 59 89
DIOVAN 57 57 60 50
SYNTHROID 56 54 61 54
CRESTOR 56 53 61 26
CELEBREX 55 52 63 117
NYSTATIN 52 52 64 220
LYRICA 51 43 65 75
CIPROFLOXACIN HCL 50 49 66 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.